<!DOCTYPE html>

<html>
    <head>
        <title>graphics</title>
        <meta charset="utf-8">
        <link rel="stylesheet" href="styles.css"/>
    </head>

    <body>
        <header>
             <nav>
                <div class="homepage">
                    <a href="index.html">home</a>
                </div>    
                <div>
                    <a class="calculatorpage" href="index.html">Calculator</a>
                </div>    
                <div>
                    <a class="graphicspage" href="#">Graphics</a>
                </div>    
                <div>
                    <a class="competitorspage" href="competitors.html">Competitors</a>
                </div>    
            </nav>
        </header>
    
    <section>
        <h1>
            Xarelto<sup><small>&reg;</small></sup>: An Effective Treatment Option<br>in Your VTE Patients with Cancer<sup><small>a,8</small></sup>
        </h1>
        <div class="patients">
            <p>
                %PATIENTS<sup><small>b</small></sup>
            </p>    
        </div>
        <div class="graph">
            <p class="grad_upper_text">
                HR 0.69;<br> 95% CI 0.36-1.33
            </p>
            <div class="left_grade">
                <ul>
                    <li>
                        <p>
                            8
                        </p>
                    </li>
                    <li>
                        <p>
                            7
                        </p>
                    </li>
                    <li>
                        <p>
                            6
                        </p>
                    </li>
                    <li>
                        <p>
                            5
                        </p>
                    </li>
                    <li>
                        <p>
                            4
                        </p>
                    </li>
                    <li>
                        <p>
                            3
                        </p>
                    </li>
                    <li>
                        <p>
                            2
                        </p>
                    </li>
                    <li>
                        <p>
                            1
                        </p>
                    </li>
                    <li>
                        <p>
                            0
                        </p>
                    </li>
                </ul>
            </div>
            <ul class="grades">
                <div class="grade"></div>
                <div class="grade"></div>
                <div class="grade"></div>
                <div class="grade"></div>
                <div class="grade"></div>
                <div class="grade"></div>
                <div class="grade"></div>
                <div class="grade"></div>
            </ul>
            <div class="grade_line_blue"></div>
            <div class="graphics_colomns">
                <div class="graph_colomn left_col">
                    <p class="col_text upper_text">
                        7.1 <br> n=20/281
                    </p>
                    <p class="col_text">
                        ENOXAPARIN / <br>VKA
                    </p>
                </div>
                <div class="graph_colomn right_col">
                    <p class="col_text upper_text">
                        5.1 <br> n=16/316
                    </p>
                    <p class="col_text">
                        XARELTO
                    </p>
                </div>
            </div>
            <p class="grad_zero">
                0
            </p>
            <p class="grad_lower_text">
                Cancer    
            </p>
        </div>
        <div class="patient_image"></div>
    </section>
    
    <footer>
        <p>
            <sup><small>a</small></sup>Xarelto is contraindicated in lesions or conditions, if they are considered to be a significant risk for major<br>bleeding, which may include the presence of malignant neoplasms at high risk of bleeding.<br><sup><small>b</small></sup>Outcome: symptomatic, recurrent VTE. 
        </p>    
    </footer>
    </body>
    <script src="script.js"></script>
</html>
